The Food and Drug Administration extended the approval of the oral anticancer drug for the treatment of patients with the most common sort of liver cancer, Bayer said.
The drug has already been approved in Europe for the treatment of liver cancer, and has been approved since 2005 for the treatment of advanced kidney cancer in more than 60 countries including the U.S. and the European Union.
"This milestone will likely establish Nexavar as the standard systemic therapy for the treatment of liver cancer and is a turning point in improving treatment outcomes in patients facing the devastating impact of this disease," said Arthur Higgins, chairman of Bayer HealthCare AG.
Bayer shares were down 0.2 percent at Ђ53.92 (US$79.09) in Frankfurt trading.
Putin's official spokesman Dmitry Peskov commented on remarks in the US media about failures in launching nuclear-capable missiles in Russia
The Buk system that shot down MH17 belonged to the 53rd SAM missile brigade of the Russian Ministry of Defense, investigators say after looking at a few pictures on the net
It has long been understood that the West has been trying to subject Russian borders to total control. We have not seen such activity even during the Cold War